Kevin Mcraith

Biography

As CEO, Kevin has led the WellDoc® team in the successful launch and continued development of the digital therapeutic for people living with type 2 diabetes, BlueStar®. Under his leadership, WellDoc has expanded its suite of BlueStar products to include: BlueStar® Rx, BlueStar® and BlueStar® C. Kevin oversees all WellDoc business related to enterprise strategy and has engineered an innovative commercial approach to position BlueStar in the marketplace to attract key investors and partnerships that include, Johnson & Johnson, Samsung and Merck GHI. He has been instrumental in positioning WellDoc as the leading digital health company in the development of digital therapeutics. Prior to joining WellDoc in 2014, Kevin had an extensive career in biotech and pharmaceuticals. He held senior commercial roles at Human Genome Sciences, Genentech and Abbott after beginning his career at Baxter Healthcare.

Research Interest

 Diabetes